New drug tested for Long-Term safety in dialysis patients
NCT ID NCT00772382
Summary
This study tested the long-term safety and effectiveness of a drug called MCI-196 for people on dialysis who have high phosphate levels in their blood. It involved 116 adult patients on stable dialysis treatment. The main goal was to see how safe the drug was over a year, while also checking if it could effectively control phosphate levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Los Angeles, California, United States
-
Study site
Orange, California, United States
-
Study site
Tarzana, California, United States
-
Study site
Orlando, Florida, United States
-
Study site
Pembroke Pines, Florida, United States
-
Study site
Atlanta, Georgia, United States
-
Study site
Gurnee, Illinois, United States
-
Study site
Evansville, Indiana, United States
-
Study site
Baton Rouge, Louisiana, United States
-
Study site
New Orleans, Louisiana, United States
-
Study site
Northport, New York, United States
-
Study site
Durham, North Carolina, United States
-
Study site
Oklahoma City, Oklahoma, United States
-
Study site
Nashville, Tennessee, United States
-
Study site
Houston, Texas, United States
-
Study site
Burlington, Vermont, United States
-
Study site
Chesapeake, Virginia, United States
-
Study site
Kamloops, British Columbia, Canada
-
Study site
London, Ontario, Canada
-
Study site
Toronto, Ontario, Canada
-
Study site
Montreal, Quebec, Canada
Conditions
Explore the condition pages connected to this study.